Novel frameshift variant of the CFTR gene: S511Lfs*2 from phenotype to molecular predictions.
Thaiane RispoliGrazielle Motta RodriguesMayara Jorgens PradoLeonardo Araújo PintoMarcelo Tadday RodriguesCynthia Rocha DulliusTarciana GrandiCláudia Maria Dornelles da SilvaJosé Eduardo VargasMaurício Menegatti RigoMaria Lucia RossettiPublished in: Molecular biology reports (2020)
Cystic fibrosis (CF) is a genetic disease caused by variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. There are over 2,000 different pathogenic and non-pathogenic variants described in association with a broad clinical heterogeneity. In this work, we identified a novel variant S511Lfs*2 in CFTR gene that has not been reported in patients with CF. The patient was a female genotyped with c.1000C>T (legacy name: R334W) variant (pathogenic, CF-causing) and the novel variant (S511Lfs*2). We verified the amino acid sequence, the protein structure, and predicted the pathogenicity employing computational analysis. Our findings showed that S511Lfs*2 is a frameshift variant and suggest that it is associated with severe CF phenotype, as it leads to a lack of CFTR protein synthesis, and consequently the loss of its functional activity.